_id
691721393c536f8df2316900
Ticker
TRDA
Name
Entrada Therapeutics Inc
Exchange
NASDAQ
Address
One Design Center Place, Boston, MA, United States, 02210
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.entradatx.com
Description
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV")-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programmes for the potential treatment of neuromuscular and ocular diseases, among others. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Last Close
10.81
Volume
134382
Current Price
11.08
Change
2.4976873265494874
Last Updated
2025-12-04T14:23:29.416Z
Image
https://logo.clearbit.com/www.entradatx.com
Ipo Date
2021-10-29T00:00:00.000Z
Market Cap
384867648
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.994
Sentiment Sources
5
Rating
4.5
Target Price
16.5
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1614000
Cost Of Revenue
38361000
Gross Profit
-36747000
Operating Expenses
10304000
Operating Income
-47051000
Interest Expense
-
Pretax Income
-43480000
Net Income
-44134000
Eps
-1.0644299953738996
Dividends Per Share
-
Shares Outstanding
38219232
Income Tax Expense
654000
EBITDA
-42250000
Operating Margin
-2915.1796778190833
Total Other Income Expense Net
3571000
Cash
93286000
Short Term Investments
233552000
Receivables
3196000
Inventories
-
Total Current Assets
338257000
Property Plant Equipment
70528000
Total Assets
412898000
Payables
3166000
Short Term Debt
4350000
Long Term Debt
-
Total Liabilities
72182000
Equity
340716000
Depreciation
1200000
Change In Working Capital
10214000
Cash From Operations
-28313000
Capital Expenditures
171000
Cash From Investing
49109000
Cash From Financing
8000
Net Change In Cash
20804000
PE
-
PB
1.34835241773207
ROE
-12.953310088167273
ROA
-10.688838405611072
FCF
-28484000
Fcf Percent
-17.64807930607187
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1614000
Quarters > 0 > income Statement > cost Of Revenue
38361000
Quarters > 0 > income Statement > gross Profit
-36747000
Quarters > 0 > income Statement > operating Expenses
10304000
Quarters > 0 > income Statement > operating Income
-47051000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-43480000
Quarters > 0 > income Statement > net Income
-44134000
Quarters > 0 > income Statement > eps
-1.0644299953738996
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
41462567
Quarters > 0 > income Statement > income Tax Expense
654000
Quarters > 0 > income Statement > EBITDA
-42250000
Quarters > 0 > income Statement > operating Margin
-2915.1796778190833
Quarters > 0 > income Statement > total Other Income Expense Net
3571000
Quarters > 0 > balance Sheet > cash
93286000
Quarters > 0 > balance Sheet > short Term Investments
233552000
Quarters > 0 > balance Sheet > receivables
3196000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
338257000
Quarters > 0 > balance Sheet > property Plant Equipment
70528000
Quarters > 0 > balance Sheet > total Assets
412898000
Quarters > 0 > balance Sheet > payables
3166000
Quarters > 0 > balance Sheet > short Term Debt
4350000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
72182000
Quarters > 0 > balance Sheet > equity
340716000
Quarters > 0 > cash Flow > net Income
-44134000
Quarters > 0 > cash Flow > depreciation
1200000
Quarters > 0 > cash Flow > change In Working Capital
10214000
Quarters > 0 > cash Flow > cash From Operations
-28313000
Quarters > 0 > cash Flow > capital Expenditures
171000
Quarters > 0 > cash Flow > cash From Investing
49109000
Quarters > 0 > cash Flow > cash From Financing
8000
Quarters > 0 > cash Flow > net Change In Cash
20804000
Quarters > 0 > ratios > PE
-1.0644299953738996
Quarters > 0 > ratios > PB
1.34835241773207
Quarters > 0 > ratios > ROE
-12.953310088167273
Quarters > 0 > ratios > ROA
-10.688838405611072
Quarters > 0 > ratios > FCF
-28484000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-17.64807930607187
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1950000
Quarters > 1 > income Statement > cost Of Revenue
1100000
Quarters > 1 > income Statement > gross Profit
1950000
Quarters > 1 > income Statement > operating Expenses
48799000
Quarters > 1 > income Statement > operating Income
-46849000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-42925000
Quarters > 1 > income Statement > net Income
-43103000
Quarters > 1 > income Statement > eps
-1.0426715692203488
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
41339000
Quarters > 1 > income Statement > income Tax Expense
178000
Quarters > 1 > income Statement > EBITDA
-45815000
Quarters > 1 > income Statement > operating Margin
-2402.5128205128203
Quarters > 1 > income Statement > total Other Income Expense Net
3924000
Quarters > 1 > balance Sheet > cash
72482000
Quarters > 1 > balance Sheet > short Term Investments
281530000
Quarters > 1 > balance Sheet > receivables
1180000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
369146000
Quarters > 1 > balance Sheet > property Plant Equipment
75488000
Quarters > 1 > balance Sheet > total Assets
448783000
Quarters > 1 > balance Sheet > payables
1857000
Quarters > 1 > balance Sheet > short Term Debt
5462000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
69278000
Quarters > 1 > balance Sheet > equity
379505000
Quarters > 1 > cash Flow > net Income
-43103000
Quarters > 1 > cash Flow > depreciation
1034000
Quarters > 1 > cash Flow > change In Working Capital
8493000
Quarters > 1 > cash Flow > cash From Operations
-29489000
Quarters > 1 > cash Flow > capital Expenditures
275000
Quarters > 1 > cash Flow > cash From Investing
33797000
Quarters > 1 > cash Flow > cash From Financing
337000
Quarters > 1 > cash Flow > net Change In Cash
4645000
Quarters > 1 > ratios > PE
-1.0426715692203488
Quarters > 1 > ratios > PB
1.2069303961739632
Quarters > 1 > ratios > ROE
-11.357689622007614
Quarters > 1 > ratios > ROA
-9.60441906221938
Quarters > 1 > ratios > FCF
-29764000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-15.263589743589744
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
20558000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
20558000
Quarters > 2 > income Statement > operating Expenses
42348000
Quarters > 2 > income Statement > operating Income
-21790000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17349000
Quarters > 2 > income Statement > net Income
-17349000
Quarters > 2 > income Statement > eps
-0.4223839898719384
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
41074000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-20844000
Quarters > 2 > income Statement > operating Margin
-105.9928008561144
Quarters > 2 > income Statement > total Other Income Expense Net
4441000
Quarters > 2 > balance Sheet > cash
67837000
Quarters > 2 > balance Sheet > short Term Investments
314678000
Quarters > 2 > balance Sheet > receivables
2044000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
403193000
Quarters > 2 > balance Sheet > property Plant Equipment
79097000
Quarters > 2 > balance Sheet > total Assets
486479000
Quarters > 2 > balance Sheet > payables
2188000
Quarters > 2 > balance Sheet > short Term Debt
6510000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
69219000
Quarters > 2 > balance Sheet > equity
417260000
Quarters > 2 > cash Flow > net Income
-17349000
Quarters > 2 > cash Flow > depreciation
946000
Quarters > 2 > cash Flow > change In Working Capital
-25853000
Quarters > 2 > cash Flow > cash From Operations
-38507000
Quarters > 2 > cash Flow > capital Expenditures
1144000
Quarters > 2 > cash Flow > cash From Investing
4783000
Quarters > 2 > cash Flow > cash From Financing
350000
Quarters > 2 > cash Flow > net Change In Cash
-33374000
Quarters > 2 > ratios > PE
-0.4223839898719384
Quarters > 2 > ratios > PB
1.0906866701816613
Quarters > 2 > ratios > ROE
-4.157839236926616
Quarters > 2 > ratios > ROA
-3.5662382137769564
Quarters > 2 > ratios > FCF
-39651000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.9287382041054577
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
37398000
Quarters > 3 > income Statement > cost Of Revenue
992000
Quarters > 3 > income Statement > gross Profit
37398000
Quarters > 3 > income Statement > operating Expenses
43265000
Quarters > 3 > income Statement > operating Income
-5867000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-739000
Quarters > 3 > income Statement > net Income
1131000
Quarters > 3 > income Statement > eps
0.02627148225026883
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43050483
Quarters > 3 > income Statement > income Tax Expense
-1870000
Quarters > 3 > income Statement > EBITDA
-4875000
Quarters > 3 > income Statement > operating Margin
-15.688004706134018
Quarters > 3 > income Statement > total Other Income Expense Net
5128000
Quarters > 3 > balance Sheet > cash
101211000
Quarters > 3 > balance Sheet > short Term Investments
318787000
Quarters > 3 > balance Sheet > receivables
3680000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
440039000
Quarters > 3 > balance Sheet > property Plant Equipment
82048000
Quarters > 3 > balance Sheet > total Assets
526321000
Quarters > 3 > balance Sheet > payables
4259000
Quarters > 3 > balance Sheet > short Term Debt
7559000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
97643000
Quarters > 3 > balance Sheet > equity
428678000
Quarters > 3 > cash Flow > net Income
1131000
Quarters > 3 > cash Flow > depreciation
992000
Quarters > 3 > cash Flow > change In Working Capital
-35921000
Quarters > 3 > cash Flow > cash From Operations
-31605000
Quarters > 3 > cash Flow > capital Expenditures
635000
Quarters > 3 > cash Flow > cash From Investing
53365000
Quarters > 3 > cash Flow > cash From Financing
1402000
Quarters > 3 > cash Flow > net Change In Cash
23162000
Quarters > 3 > ratios > PE
0.02627148225026883
Quarters > 3 > ratios > PB
1.1127217903414683
Quarters > 3 > ratios > ROE
0.2638343931808957
Quarters > 3 > ratios > ROA
0.21488787261006115
Quarters > 3 > ratios > FCF
-32240000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.8620781859992513
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
210782000
Annuals > 0 > income Statement > cost Of Revenue
3773000
Annuals > 0 > income Statement > gross Profit
210782000
Annuals > 0 > income Statement > operating Expenses
163771000
Annuals > 0 > income Statement > operating Income
47011000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
66485000
Annuals > 0 > income Statement > net Income
65626000
Annuals > 0 > income Statement > eps
1.6825885188318848
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
39003000
Annuals > 0 > income Statement > income Tax Expense
859000
Annuals > 0 > income Statement > EBITDA
50784000
Annuals > 0 > income Statement > operating Margin
22.30313783909442
Annuals > 0 > income Statement > total Other Income Expense Net
19474000
Annuals > 0 > balance Sheet > cash
101211000
Annuals > 0 > balance Sheet > short Term Investments
318787000
Annuals > 0 > balance Sheet > receivables
3680000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
440039000
Annuals > 0 > balance Sheet > property Plant Equipment
82048000
Annuals > 0 > balance Sheet > total Assets
526321000
Annuals > 0 > balance Sheet > payables
4259000
Annuals > 0 > balance Sheet > short Term Debt
7559000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
97643000
Annuals > 0 > balance Sheet > equity
428678000
Annuals > 0 > cash Flow > net Income
65626000
Annuals > 0 > cash Flow > depreciation
3773000
Annuals > 0 > cash Flow > change In Working Capital
-118853000
Annuals > 0 > cash Flow > cash From Operations
-41557000
Annuals > 0 > cash Flow > capital Expenditures
3158000
Annuals > 0 > cash Flow > cash From Investing
-27798000
Annuals > 0 > cash Flow > cash From Financing
102964000
Annuals > 0 > cash Flow > net Change In Cash
33609000
Annuals > 0 > ratios > PE
1.6825885188318848
Annuals > 0 > ratios > PB
0.9162126584522648
Annuals > 0 > ratios > ROE
15.308926513606949
Annuals > 0 > ratios > ROA
12.46881655871607
Annuals > 0 > ratios > FCF
-44715000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.2121386076609957
Annuals > 0 > health Score
70
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
129013000
Annuals > 1 > income Statement > cost Of Revenue
99884000
Annuals > 1 > income Statement > gross Profit
129013000
Annuals > 1 > income Statement > operating Expenses
132175000
Annuals > 1 > income Statement > operating Income
-3162000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
12056000
Annuals > 1 > income Statement > net Income
-6685000
Annuals > 1 > income Statement > eps
-0.20226733666322555
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
33050319
Annuals > 1 > income Statement > income Tax Expense
18741000
Annuals > 1 > income Statement > EBITDA
-321000
Annuals > 1 > income Statement > operating Margin
-2.450915799183028
Annuals > 1 > income Statement > total Other Income Expense Net
15218000
Annuals > 1 > balance Sheet > cash
67602000
Annuals > 1 > balance Sheet > short Term Investments
284367000
Annuals > 1 > balance Sheet > receivables
5878000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
369771000
Annuals > 1 > balance Sheet > property Plant Equipment
92681000
Annuals > 1 > balance Sheet > total Assets
469192000
Annuals > 1 > balance Sheet > payables
3277000
Annuals > 1 > balance Sheet > short Term Debt
7909000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
226832000
Annuals > 1 > balance Sheet > equity
242360000
Annuals > 1 > cash Flow > net Income
-6685000
Annuals > 1 > cash Flow > depreciation
2841000
Annuals > 1 > cash Flow > change In Working Capital
136315000
Annuals > 1 > cash Flow > cash From Operations
139803000
Annuals > 1 > cash Flow > capital Expenditures
5614000
Annuals > 1 > cash Flow > cash From Investing
-138395000
Annuals > 1 > cash Flow > cash From Financing
21037000
Annuals > 1 > cash Flow > net Change In Cash
22445000
Annuals > 1 > ratios > PE
-0.20226733666322555
Annuals > 1 > ratios > PB
1.3732328450651923
Annuals > 1 > ratios > ROE
-2.7582934477636574
Annuals > 1 > ratios > ROA
-1.424789851489369
Annuals > 1 > ratios > FCF
134189000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
1.0401199879081953
Annuals > 1 > health Score
50
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
25260000
Annuals > 2 > income Statement > cost Of Revenue
1895000
Annuals > 2 > income Statement > gross Profit
-1895000
Annuals > 2 > income Statement > operating Expenses
97248000
Annuals > 2 > income Statement > operating Income
-97248000
Annuals > 2 > income Statement > interest Expense
2632000
Annuals > 2 > income Statement > pretax Income
-94616000
Annuals > 2 > income Statement > net Income
-87457000
Annuals > 2 > income Statement > eps
-2.7947505204946026
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
31293312
Annuals > 2 > income Statement > income Tax Expense
-7159000
Annuals > 2 > income Statement > EBITDA
-95353000
Annuals > 2 > income Statement > operating Margin
-384.98812351543944
Annuals > 2 > income Statement > total Other Income Expense Net
2632000
Annuals > 2 > balance Sheet > cash
45157000
Annuals > 2 > balance Sheet > short Term Investments
143555000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
209875000
Annuals > 2 > balance Sheet > property Plant Equipment
33021000
Annuals > 2 > balance Sheet > total Assets
252056000
Annuals > 2 > balance Sheet > payables
5990000
Annuals > 2 > balance Sheet > short Term Debt
8406000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
39502000
Annuals > 2 > balance Sheet > equity
212554000
Annuals > 2 > cash Flow > net Income
-94616000
Annuals > 2 > cash Flow > depreciation
1895000
Annuals > 2 > cash Flow > change In Working Capital
-11111000
Annuals > 2 > cash Flow > cash From Operations
-93786000
Annuals > 2 > cash Flow > capital Expenditures
2887000
Annuals > 2 > cash Flow > cash From Investing
-148650000
Annuals > 2 > cash Flow > cash From Financing
479000
Annuals > 2 > cash Flow > net Change In Cash
-245907000
Annuals > 2 > ratios > PE
-2.7947505204946026
Annuals > 2 > ratios > PB
1.4825580880152809
Annuals > 2 > ratios > ROE
-41.145779425463644
Annuals > 2 > ratios > ROA
-34.69744818611737
Annuals > 2 > ratios > FCF
-96673000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-3.8271179730799685
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1117000
Annuals > 3 > income Statement > gross Profit
-1117000
Annuals > 3 > income Statement > operating Expenses
51127000
Annuals > 3 > income Statement > operating Income
-51127000
Annuals > 3 > income Statement > interest Expense
31000
Annuals > 3 > income Statement > pretax Income
-51158000
Annuals > 3 > income Statement > net Income
-50072000
Annuals > 3 > income Statement > eps
-1.6036209705147932
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
31224336
Annuals > 3 > income Statement > income Tax Expense
-1086000
Annuals > 3 > income Statement > EBITDA
-50010000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-31000
Annuals > 3 > balance Sheet > cash
291064000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
872000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
298700000
Annuals > 3 > balance Sheet > property Plant Equipment
6261000
Annuals > 3 > balance Sheet > total Assets
305833000
Annuals > 3 > balance Sheet > payables
706000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
7115000
Annuals > 3 > balance Sheet > equity
298718000
Annuals > 3 > cash Flow > net Income
-51158000
Annuals > 3 > cash Flow > depreciation
1117000
Annuals > 3 > cash Flow > change In Working Capital
-3421000
Annuals > 3 > cash Flow > cash From Operations
-50862000
Annuals > 3 > cash Flow > capital Expenditures
4580000
Annuals > 3 > cash Flow > cash From Investing
-4580000
Annuals > 3 > cash Flow > cash From Financing
307461000
Annuals > 3 > cash Flow > net Change In Cash
252019000
Annuals > 3 > ratios > PE
-1.6036209705147932
Annuals > 3 > ratios > PB
1.052594967561379
Annuals > 3 > ratios > ROE
-16.7622975515369
Annuals > 3 > ratios > ROA
-16.372333920799914
Annuals > 3 > ratios > FCF
-55442000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-1.0644299953738996
Valuation > metrics > PB
1.34835241773207
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-12.953310088167273
Profitability > metrics > ROA
-13.047475735904948
Profitability > metrics > Net Margin
-27.34448574969021
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2118538606933634
Risk > metrics > Interest Coverage
-38.25284552845528
Risk > final Score
-93
Risk > verdict
High
Liquidity > metrics > Current Ratio
45.00492283129324
Liquidity > metrics > Quick Ratio
45.00492283129324
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
6
Prev Risks > 0
-5
Prev Risks > 1
35
Prev Risks > 2
54
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:19:38.417Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.06
Earnings History > 0 > eps Estimate
-0.9912
Earnings History > 0 > eps Difference
-0.0688
Earnings History > 0 > surprise Percent
-6.9411
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.04
Earnings History > 1 > eps Estimate
-0.82
Earnings History > 1 > eps Difference
-0.22
Earnings History > 1 > surprise Percent
-26.8293
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.42
Earnings History > 2 > eps Estimate
-0.775
Earnings History > 2 > eps Difference
0.355
Earnings History > 2 > surprise Percent
45.8065
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-03
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.03
Earnings History > 3 > eps Estimate
-0.67
Earnings History > 3 > eps Difference
0.7
Earnings History > 3 > surprise Percent
104.4776
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.35
Earnings History > 4 > eps Estimate
-0.73
Earnings History > 4 > eps Difference
0.38
Earnings History > 4 > surprise Percent
52.0548
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
1.5499
Earnings History > 5 > eps Estimate
0.14
Earnings History > 5 > eps Difference
1.4099
Earnings History > 5 > surprise Percent
1007.0714
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.68
Earnings History > 6 > eps Estimate
-0.59
Earnings History > 6 > eps Difference
1.27
Earnings History > 6 > surprise Percent
215.2542
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-13
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.29
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
-0.12
Earnings History > 7 > surprise Percent
-70.5882
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
1.02
Earnings History > 8 > eps Estimate
-0.74
Earnings History > 8 > eps Difference
1.76
Earnings History > 8 > surprise Percent
237.8378
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.78
Earnings History > 9 > eps Estimate
-0.69
Earnings History > 9 > eps Difference
-0.09
Earnings History > 9 > surprise Percent
-13.0435
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.21
Earnings History > 10 > eps Estimate
0.97
Earnings History > 10 > eps Difference
-1.18
Earnings History > 10 > surprise Percent
-121.6495
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-06
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.79
Earnings History > 11 > eps Estimate
-0.83
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
4.8193
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.8
Earnings History > 12 > eps Estimate
-0.76
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-5.2632
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.74
Earnings History > 13 > eps Estimate
-0.72
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-2.7778
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.69
Earnings History > 14 > eps Estimate
-0.65
Earnings History > 14 > eps Difference
-0.04
Earnings History > 14 > surprise Percent
-6.1538
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-15
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.89
Earnings History > 15 > eps Estimate
-1.28
Earnings History > 15 > eps Difference
0.39
Earnings History > 15 > surprise Percent
30.4688
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-12-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-9.78
Earnings History > 16 > eps Estimate
-0.87
Earnings History > 16 > eps Difference
-8.91
Earnings History > 16 > surprise Percent
-1024.1379
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-01
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.45
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.45
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-7.0819
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-7.0819
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-7.0819
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-7.0819
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-06-30
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-5.1812
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-5.1812
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-5.1812
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-5.1812
Earnings History > 21 > surprise Percent
-
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV")-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programmes for the potential treatment of neuromuscular and ocular diseases, among others. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATRDA Stock Analysis and Forecast - Morning Star Patterns & You’ll Thank Yourself in 6 Months earlytimes.in
Read more →5AM Venture Management LLC Has $28.95 Million Stake in Entrada Therapeutics, Inc. $TRDA - MarketBeat
12/13/2025
5AM Venture Management LLC Has $28.95 Million Stake in Entrada Therapeutics, Inc. $TRDA MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$16.5
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 90.42% of the total shares of Entrada Therapeutics Inc
1.
Baker Bros Advisors LP(12.7923%)
since
2025/06/30
2.
Mpm Asset Management, LLC(11.5179%)
since
2025/06/30
3.
5AM Venture Management, LLC(11.3268%)
since
2025/06/30
4.
T. Rowe Price Associates, Inc.(6.7499%)
since
2025/06/30
5.
BlackRock Inc(5.3163%)
since
2025/06/30
6.
Vanguard Group Inc(4.2192%)
since
2025/06/30
7.
US Small-Cap Growth II Equity Comp(4.0026%)
since
2025/06/30
8.
HHG PLC(3.9995%)
since
2025/06/30
9.
T. Rowe Price New Horizons(3.5888%)
since
2025/07/31
10.
Wellington Management Company LLP(2.7886%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(2.4505%)
since
2025/07/31
12.
StepStone Group LLC(2.0014%)
since
2025/06/30
13.
iShares Russell 2000 ETF(1.7374%)
since
2025/08/31
14.
Geode Capital Management, LLC(1.6604%)
since
2025/06/30
15.
TCG Crossover Management, LLC(1.5379%)
since
2025/06/30
16.
FMR Inc(1.3043%)
since
2025/06/30
17.
State Street Corp(1.3036%)
since
2025/06/30
18.
T. Rowe Price New Horizons Tr-A(1.2072%)
since
2025/06/30
19.
Dimensional Fund Advisors, Inc.(1.1147%)
since
2025/06/30
20.
Renaissance Technologies Corp(0.9977%)
since
2025/06/30
21.
Northern Trust Corp(0.7895%)
since
2025/06/30
22.
Fidelity Small Cap Index(0.7353%)
since
2025/06/30
23.
Vanguard Institutional Extnd Mkt Idx Tr(0.6727%)
since
2025/07/31
24.
iShares Russell 2000 Value ETF(0.6413%)
since
2025/08/31
25.
Royce & Associates, LP(0.5869%)
since
2025/06/30
26.
Jacobs Levy Equity Management, Inc.(0.5803%)
since
2025/06/30
27.
T. Rowe Price Health Sciences(0.5708%)
since
2025/07/31
28.
Charles Schwab Investment Management Inc(0.5355%)
since
2025/06/30
29.
Millennium Management LLC(0.4478%)
since
2025/06/30
30.
Fidelity Growth Compy Commingled Pl S(0.4311%)
since
2025/07/31
31.
Royce Capital Small-Cap Inv(0.4014%)
since
2025/06/30
32.
Vanguard Russell 2000 ETF(0.353%)
since
2025/07/31
33.
iShares Biotechnology ETF(0.3484%)
since
2025/08/31
34.
Fidelity Extended Market Index(0.3301%)
since
2025/07/31
35.
Schwab US Small-Cap ETF™(0.2835%)
since
2025/08/30
36.
Federated Hermes MDT SCC Institutional(0.2391%)
since
2025/06/30
37.
Federated Hermes MDT Small Cap Core IS(0.2391%)
since
2025/06/30
38.
DFA US Small Cap Value I(0.2195%)
since
2025/07/31
39.
State St Russell Sm Cap® Indx SL Cl I(0.2169%)
since
2025/08/31
40.
Royce Small-Cap Value Service(0.1856%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.06
EPS Estimate
-0.9912
EPS Difference
-0.0688
Surprise Percent
-6.9411%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.